Why is Fluicell AB ?
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at SEK -0.9 MM
- NET SALES(HY) Higher at SEK 9.93 MM
- ROCE(HY) Highest at -15.26%
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 214.13%, its profits have risen by 46.3%
- Along with generating 214.13% returns in the last 1 year, the stock has outperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to Fluicell AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Fluicell AB for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at SEK -0.9 MM
Higher at SEK 9.93 MM
Highest at -15.26%
Highest at SEK 2.54 MM
Fallen by -102.54% (YoY
Highest at 3.87 times
Highest at SEK 3.31 MM
Highest at SEK 3.31 MM
Highest at SEK 2.41
At SEK 0.09 MM has Grown at 56.67%
Highest at -9.13 %
Lowest at SEK 3.56 MM
Here's what is working for Fluicell AB
Net Sales (SEK MM)
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
Operating Cash Flows (SEK MM)
Operating Profit (SEK MM)
Net Sales (SEK MM)
Pre-Tax Profit (SEK MM)
Net Profit (SEK MM)
EPS (SEK)
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Fluicell AB
Debt-Equity Ratio
Interest Paid (SEK MM)
Cash and Cash Equivalents






